Raloxifene [orch, phsu]
Review [inpr]
Osteoporosis, Post-Menopausal [dsyn]
Raloxifene [orch, phsu]
Selective Estrogen Receptor Modulator [horm, phsu]
mimics [topp]
effects [qlco]
Estrogens [horm, phsu, strd]
Bone [bpoc]
Cardiovascular system [bdsy]
functioning [ftcn]
Antiestrogen [phsu]
Endometrial [spco]
Breast tissue [bpoc]
placebo controlled study [inpr, resa]
Involving [ftcn]
postmenopausal [tmco]
Women [popg]
Patients [podg]
Osteoporosis [dsyn]
Raloxifene [orch, phsu]
mg day [qnco]
effective [qlco]
Increasing [ftcn]
Bone Mineral Density [clna]
month [tmco]
mg day [qnco]
Recommended [idcn]
Dosage [qnco]
Increase [ftcn]
Reported [inpr]
Lumbar spine [bpoc]
Femoral Neck [bpoc]
Hip [bpoc]
Equal [qlco]
placebo [topp]
Raloxifene [orch, phsu]
mg day [qnco]
Decreased [qnco]
Risk [qlco]
Vertebral Fracture [inpo]
month [tmco]
postmenopausal [tmco]
Patients [podg]
Osteoporosis [dsyn]
reductions [npop]
Radiographic [npop]
Fracture [inpo]
Risk [qlco]
placebo [topp]
Occurred [acty]
Patients [podg]
Fractures [inpo]
baseline [bodm]
Raloxifene [orch, phsu]
Not [ftcn]
Affect [menp]
Overall [inpr]
Incidence [qnco]
Fractures [inpo]
reduction [npop]
Incidence [qnco]
Ankle fracture [inpo]
Reported [inpr]
Comparison [acty]
placebo [topp]
postmenopausal [tmco]
Women [popg]
Reduced [qlco]
Serum [bdsu]
Level [qlco]
Low Density Lipoprotein Cholesterol [bacs, strd]
baseline [bodm]
Compared [acty]
placebo [topp]
High Density Lipoprotein Cholesterol [bacs, lipd]
Triglyceride level [lbtr]
Unaffected [cnce]
Raloxifene [orch, phsu]
mg day [qnco]
Reduced [qlco]
Risk [qlco]
Invasive Breast Cancer [neop]
median [spco]
months [tmco]
Follow-up [fndg]
postmenopausal [tmco]
Patients [podg]
Osteoporosis [dsyn]
History [ocdi]
Breast Cancer [neop]
Relative Risk [qnco]
reduction [npop]
Reported [inpr]
Estrogen receptor positive [lbtr]
Invasive Breast Cancer [neop]
Estrogen receptor negative [lbtr]
Cancer Risk [qnco]
Unaffected [cnce]
Raloxifene [orch, phsu]
Raloxifene [orch, phsu]
Well [qlco]
Clinical Trials [resa]
Dosages [qnco]
mg day [qnco]
adverse events [fndg]
Thought [menp]
To [qlco]
Raloxifene [orch, phsu]
treatment [ftcn]
Hot flushes [sosy]
Leg cramps [sosy]
Venous Thromboembolism [patf]
Only [qnco]
Serious Adverse Event [fndg]
Thought [menp]
To [qlco]
Raloxifene [orch, phsu]
treatment [ftcn]
Relative Risk [qnco]
Compared [acty]
placebo [topp]
treatment [ftcn]
Reported [inpr]
Patients [podg]
Osteoporosis [dsyn]
Vaginal Bleeding [patf]
Occurred [acty]
Equal [qlco]
Raloxifene [orch, phsu]
treated [topp]
Women [popg]
Reported [inpr]
Receive [qlco]
Estrogens [horm, phsu, strd]
Hormone replacement therapy [topp]
Raloxifene [orch, phsu]
treatment [ftcn]
Not [ftcn]
Associated [qlco]
effects [qlco]
Endometrium [bpoc]
Conclusions [idcn]
Raloxifene [orch, phsu]
Increase [ftcn]
Bone Mineral Density [clna]
postmenopausal [tmco]
Women [popg]
Vertebral Fracture [inpo]
Risk [qlco]
Patients [podg]
Osteoporosis [dsyn]
Clinical Trials [resa]
Raloxifene [orch, phsu]
Well [qlco]
Compared [acty]
placebo [topp]
Hormone replacement therapy [topp]
Hot flushes [sosy]
Women [popg]
vasomotor symptom [sosy]
lack [qlco]
effects [qlco]
Endometrium [bpoc]
reduction [npop]
Invasive Breast Cancer [neop]
Incidence [qnco]
Raloxifene [orch, phsu]
Attractive [qlco]
Alternative [cnce]
Hormone replacement therapy [topp]
Management [ocac]
Osteoporosis, Post-Menopausal [dsyn]
